Blue Bird [BLBD] vs Hyster-Yale [HY] Detailed Stock Comparison
Blue Bird
NASDAQ
Loading...
Hyster-Yale
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Blue Bird wins in 12 metrics, Hyster-Yale wins in 7 metrics, with 0 ties. Blue Bird appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Blue Bird | Hyster-Yale | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 16.76 | 30.28 | Blue Bird |
| Price-to-Book Ratio | 8.30 | 1.21 | Hyster-Yale |
| Debt-to-Equity Ratio | 41.24 | 83.99 | Blue Bird |
| PEG Ratio | 0.55 | -0.25 | Hyster-Yale |
| EV/EBITDA | 11.24 | 6.73 | Hyster-Yale |
| Profit Margin (TTM) | 8.16% | 0.56% | Blue Bird |
| Operating Margin (TTM) | 12.72% | 0.65% | Blue Bird |
| EBITDA Margin (TTM) | 12.72% | 0.65% | Blue Bird |
| Return on Equity | 64.54% | 4.55% | Blue Bird |
| Return on Assets (TTM) | 17.20% | 3.34% | Blue Bird |
| Free Cash Flow (TTM) | $95.85M | $122.90M | Hyster-Yale |
| Dividend Yield | N/A | 2.73% | N/A |
| 1-Year Return | 11.72% | -40.07% | Blue Bird |
| Price-to-Sales Ratio (TTM) | 1.31 | 0.17 | Hyster-Yale |
| Enterprise Value | $1.77B | $1.06B | Blue Bird |
| EV/Revenue Ratio | 1.25 | 0.27 | Hyster-Yale |
| Gross Profit Margin (TTM) | 21.59% | 17.58% | Blue Bird |
| Revenue per Share (TTM) | $44 | $225 | Hyster-Yale |
| Earnings per Share (Diluted) | $3.49 | $1.23 | Blue Bird |
| Beta (Stock Volatility) | 1.50 | 1.52 | Blue Bird |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Blue Bird vs Hyster-Yale Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Blue Bird | -0.98% | -3.12% | 27.49% | 39.49% | 55.87% | 41.47% |
| Hyster-Yale | 0.82% | -1.12% | -9.90% | -8.97% | -29.08% | -26.49% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Blue Bird | 11.72% | 358.89% | 381.09% | 364.74% | 475.79% | 475.79% |
| Hyster-Yale | -40.07% | 16.10% | -13.33% | -39.83% | -13.57% | -13.57% |
Performance & Financial Health Analysis: Blue Bird vs Hyster-Yale
| Metric | BLBD | HY |
|---|---|---|
| Market Information | ||
| Market Cap | $1.85B | $660.09M |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 1,150,830 | 91,316 |
| 90 Day Avg. Volume | 652,817 | 65,269 |
| Last Close | $54.68 | $36.93 |
| 52 Week Range | $30.04 - $60.45 | $34.13 - $69.28 |
| % from 52W High | -9.55% | -46.69% |
| All-Time High | $60.45 (Aug 08, 2025) | $108.13 (Mar 03, 2014) |
| % from All-Time High | -9.55% | -65.85% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.19% | -0.18% |
| Quarterly Earnings Growth | 0.27% | -0.18% |
| Financial Health | ||
| Profit Margin (TTM) | 0.08% | 0.01% |
| Operating Margin (TTM) | 0.13% | 0.01% |
| Return on Equity (TTM) | 0.65% | 0.05% |
| Debt to Equity (MRQ) | 41.24 | 83.99 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $7.05 | $30.76 |
| Cash per Share (MRQ) | $5.46 | $4.00 |
| Operating Cash Flow (TTM) | $166.45M | $143.30M |
| Levered Free Cash Flow (TTM) | $123.66M | $24.76M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 2.73% |
| Last 12-Month Dividend | N/A | $1.05 |
Valuation & Enterprise Metrics Analysis: Blue Bird vs Hyster-Yale
| Metric | BLBD | HY |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 16.76 | 30.28 |
| Forward P/E | 15.85 | 6.91 |
| PEG Ratio | 0.55 | -0.25 |
| Price to Sales (TTM) | 1.31 | 0.17 |
| Price to Book (MRQ) | 8.30 | 1.21 |
| Market Capitalization | ||
| Market Capitalization | $1.85B | $660.09M |
| Enterprise Value | $1.77B | $1.06B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.25 | 0.27 |
| Enterprise to EBITDA | 11.24 | 6.73 |
| Risk & Other Metrics | ||
| Beta | 1.50 | 1.52 |
| Book Value per Share (MRQ) | $7.05 | $30.76 |
Financial Statements Comparison: Blue Bird vs Hyster-Yale
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | BLBD | HY |
|---|---|---|
| Revenue/Sales | $358.85M | $956.60M |
| Cost of Goods Sold | $288.00M | $788.40M |
| Gross Profit | $70.85M | $168.20M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $33.71M | $7.20M |
| EBITDA | $39.27M | $22.20M |
| Pre-Tax Income | $33.60M | $-13.20M |
| Income Tax | $9.13M | $200,000 |
| Net Income (Profit) | $26.05M | $-13.40M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | BLBD | HY |
|---|---|---|
| Cash & Equivalents | $130.75M | $77.20M |
| Total Current Assets | $328.42M | $1.45B |
| Total Current Liabilities | $226.65M | $1.05B |
| Long-Term Debt | $87.66M | $242.60M |
| Total Shareholders Equity | $190.39M | $529.40M |
| Retained Earnings | $24.72M | $377.00M |
| Property, Plant & Equipment | $104.10M | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | BLBD | HY |
|---|---|---|
| Operating Cash Flow | $46.79M | $-44.40M |
| Capital Expenditures | $-9.02M | N/A |
| Free Cash Flow | $18.75M | $-47.00M |
| Debt Repayment | $-1.32M | $-42.50M |
| Common Stock Repurchase | $-22.98M | $-4.50M |
Short Interest & Institutional Ownership Analysis
| Metric | BLBD | HY |
|---|---|---|
| Shares Short | 5.17M | 487,139 |
| Short Ratio | 12.41 | 9.53 |
| Short % of Float | 0.19% | 0.04% |
| Average Daily Volume (10 Day) | 1,150,830 | 91,316 |
| Average Daily Volume (90 Day) | 652,817 | 65,269 |
| Shares Outstanding | 32.27M | 17.42M |
| Float Shares | 31.51M | 10.05M |
| % Held by Insiders | 0.01% | 0.17% |
| % Held by Institutions | 1.13% | 0.61% |
Dividend Analysis & Yield Comparison: Blue Bird vs Hyster-Yale
| Metric | BLBD | HY |
|---|---|---|
| Last 12-Month Dividend | N/A | $1.05 |
| Last 12-Month Dividend Yield | N/A | 2.73% |
| 3-Year Avg Annual Dividend | N/A | $1.12 |
| 3-Year Avg Dividend Yield | N/A | 0.72% |
| 3-Year Total Dividends | N/A | $3.35 |
| Ex-Dividend Date | N/A | Feb 28, 2025 |